National Institutes of Health: Myocardial Infarction trials

The registry lists 69 Myocardial Infarction studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 2 2Phase 3 22No phase 45(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected AdultsCompletedNCT02344290Phase 3Results posted
• REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial InfarctionCompletedNCT00378352Phase 2Results posted
• Cardiac MRI for Patients Enrolled in INFUSE-AMICompletedNCT01059214
• Cardiovascular Disease ScreeningTerminatedNCT00483951
• Heart Function and Exercise Capacity in Patients With Hypertrophic CardiomyopathyCompletedNCT00354328
• Pharmacogenetics and Cardiovascular EventsCompletedNCT00094198
• Molecular Epidemiology of Myocardial Infarction and Stroke in Older Adults - Ancillary to CHSCompletedNCT00078429
• Vascular Interaction With Age in Myocardial InfarctionCompletedNCT00051376Not applicable
• Home Use of Automatic External Defibrillators to Treat Sudden Cardiac ArrestCompletedNCT00047411Phase 3
• Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEADCompletedNCT00031213
• MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEADCompletedNCT00031200
• Technical Development of Cardiovascular Magnetic Resonance ImagingCompletedNCT00027170
• The MI-HEART ProjectCompletedNCT00013741Not applicable
• Thrombotic, Inflammatory & Gene Markers of CVD in WomenCompletedNCT00006539
• Flavonoids and Cardiovascular DiseaseCompletedNCT00006504
• Infection and Cardiovascular DiseaseCompletedNCT00005547
• Inflammation, Infection, and Future Cardiovascular RiskCompletedNCT00005496
• Observational Aspirin Use and CVD in the Physicians' Health StudyCompletedNCT00005493
• Multi-Ethnic Study of Atherosclerosis (MESA)Active, not recruitingNCT00005487
• Stroke and MI in Users of Estrogen/ProgestogenCompletedNCT00005466
• Predictors of Cardiovascular Disease in the ElderlyCompletedNCT00005460
• Physical Activity and Cardiovascular Disease PreventionCompletedNCT00005447
• Stroke Risk in the NAS-NRC Twin RegistryCompletedNCT00005413
• Epidemiology of Coronary Heart Disease in BlacksCompletedNCT00005410
• Compliance in the Physicians' Health StudyCompletedNCT00005404
• Novel Hemostatic Cardiac Risk Factors in FraminghamCompletedNCT00005356
• Mediators of Social Support in Coronary DiseaseCompletedNCT00005344
• Homocysteine and Progression of AtherosclerosisCompletedNCT00005338
• Protein S and Myocardial InfarctionCompletedNCT00005329
• Natural History of Coronary Heart DiseaseCompletedNCT00005265
• Physicians' Health Study: Study of Low Cardiovascular Disease MortalityCompletedNCT00005252
• Triggers of Ventricular Arrhythmias (TOVA) StudyCompletedNCT00005243
• Myocardial Infarction and Current Oral Contraceptive UseCompletedNCT00005241
• Survival After Myocardial Infarction in A Biethnic Texas Community (Corpus Christi Heart Project)CompletedNCT00005198
• Predictors of Perioperative Cardiac MorbidityCompletedNCT00005197
• Worcester Heart Attack Community Surveillance StudyCompletedNCT00005196
• Insulin and Biogenic Amines in Cardiovascular DiseaseCompletedNCT00005194
• Clinical Course of Coronary Artery Disease Among BlacksCompletedNCT00005191
• Carotid Atherosclerosis Follow-up StudyCompletedNCT00005189
• Myocardial Infarction and Non-contraceptive Estrogen UseCompletedNCT00005185
• Myocardial Infarction and Past Oral Contraceptive UseCompletedNCT00005173
• Coronary Heart Disease Incidence, Mortality, and Risk Factor RelationshipsCompletedNCT00005148
• Honolulu Heart ProgramCompletedNCT00005123
• Evans County StudiesCompletedNCT00005122
• Vitamin Therapy for Prevention of StrokeCompletedNCT00004734Phase 3
• Public Access Defibrillation (PAD) Community TrialCompletedNCT00004560Phase 3
• MRI Evaluation of Chest PainCompletedNCT00001961Phase 2
• Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media ThicknessCompletedNCT00001904
• Magnetic Resonance Imaging of the Blood Vessels of the HeartCompletedNCT00001638
• The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular FunctionCompletedNCT00001629Phase 3
• The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular FunctionCompletedNCT00001628Phase 3
• Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood DonorsCompletedNCT00001589
• Azithromycin and Coronary Events Study (ACES)CompletedNCT00000617Phase 3
• Magnesium in Coronaries (MAGIC)CompletedNCT00000610Phase 3
• NHLBI Type II Coronary Intervention StudyCompletedNCT00000594Phase 3
• Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)CompletedNCT00000558Phase 3
• Enhancing Recovery in Coronary Heart Disease (ENRICHD) PatientsCompletedNCT00000557Phase 3
• Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)CompletedNCT00000542Phase 3
• Coronary Artery Bypass Graft (CABG) Patch TrialCompletedNCT00000540Phase 3
• Cardiac Arrhythmia Suppression Trial (CAST)CompletedNCT00000526Phase 3
• Thrombolysis in Myocardial Infarction (TIMI)CompletedNCT00000505Phase 3
• Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary ArteriesCompletedNCT00000503Phase 3
• Evaluation of SC-V Versus Conventional CPRCompletedNCT00000502Phase 3
• Multicenter Investigation of Limitation of Infarct Size (MILIS)CompletedNCT00000493Phase 3
• Beta-Blocker Heart Attack Trial (BHAT)CompletedNCT00000492Phase 3
• Aspirin-Myocardial Infarction Study (AMIS)CompletedNCT00000491Phase 3
• Coronary Drug Project Mortality SurveillanceCompletedNCT00000483Not applicable
• Coronary Drug ProjectCompletedNCT00000482Phase 3
• Thrombolysis in Myocardial Ischemia Trial (TIMI III)CompletedNCT00000472Phase 3